1. Signaling Pathways
  2. Immunology/Inflammation
  3. PD-1/PD-L1
  4. PD-1/PD-L1 Inducer

PD-1/PD-L1 Inducer

PD-1/PD-L1 Inducers (3):

Cat. No. Product Name Effect Purity
  • HY-171331
    AB-3PRGD2
    Inducer
    AB-3PRGD2 is a radiotherapeutic agent targeting integrin αvβ3. AB-3PRGD2 shows improved tumor uptake and prolonged tumor retention, leading to significantly enhanced tumor growth suppression. AB-3PRGD2 can remodel the tumor immune microenvironment by upregulating PD-L1 expression and increasing tumor-infiltrating CD8+ T cells.
  • HY-P992314
    ASD141
    Inducer
    ASD141 is a mouse IgG1 antibody targeting mouse CD11b and a CD11b antagonist. ASD141 remodels the tumor microenvironment, enhances antigen presentation ability, and induces PD-L1 expression. ASD141 can be used for the research of colon cancer.
  • HY-P1610
    Asudemotide
    Inducer
    Asudemotide (S-588410) is a peptide of human DEP domain-containing protein 1A. Asudemotide is an immunostimulant. Asudemotide has a sequence of H-Glu-Tyr-Tyr-Glu-Leu-Phe-Val-Asn-Ile-OH. Asudemotide induces a tumor immune response in esophageal cancer. .